Skip to main content
. Author manuscript; available in PMC: 2019 Mar 8.
Published in final edited form as: World Neurosurg. 2018 Oct 4;121:e640–e646. doi: 10.1016/j.wneu.2018.09.179

Table 3.

Local Contral: Univariate Analysis

Freedom from Local Failure (years from XRT)
Covariate Level Number of Patients HR (95% CI) HR P Value Log-Rank P Value
Number of lesions >1 8 0.00 (0.00) 0.993 0.488
1 203 - -
Location Base of skull 136 0.69 (0.21–2.26) 0.541 0.539
Other 75 - -
XRT dose ≥45 111 0.91 (0.28–3.00) 0.879 0.879
<45 100 - -
Treatment FRT 131 1.03 (0.30–3.53) 0.963 0.963
SRS 80 - -
Median age at XRT ≥58.5 106 1.03 (0.31–3.42) 0.967 0.967
<58.5 105 - -
Upper quartile age at XRT ≥69.6 53 1.23 (0.25–5.94) 0.799 0.798
<69.6 158 - -
Median lesion size (average) ≥5.30 92 1.68 (0.47–5.96) 0.421 0.416
<5.30 90 - -
Upper quartile lesion size (average) ≥11.62 46 2.12 (0.60–7.52) 0.246 0.235
<11.62 136 - -
Median lesion size (sum) ≥5.33 91 1.80 (0.51–6.40) 0.365 0.358
<5.33 91 - -
Upper quartile lesion size (sum) ≥11.70 46 2.09 (0.59–7.41) 0.256 0.245
<11.70 136 - -
Age at XRT 211 0.99 (0.95–1.04) 0.754 -
Lesion size (average) 182 1.03 (1.01–1.05) 0.002 -
Lesion size (sum) 182 1.03 (1.01–1.05) 0.002 -

HR, hazard ratio; CI, confidence interval; SRS, stereotactic radiosurgery; FRT, fractionated radiation therapy; XRT, radiation therapy.